% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • centralstationamsterd centralstationamsterd Oct 4, 2012 1:18 PM Flag

    10 dollar target with more on the way

    The company will host an Analyst and Investor Day tomorrow in NY at 5:00pm, featuring key opinion leaders speaking about AML and the need for new treatments. Among the physicians speaking is Dr. Farhad Ravandi, principal investigator in the VALOR trial, as well as Dr. Eric Feldman, Chair of the VALOR steering committee. We would expect these physicians to be quite positive on the drug candidate, particularly given the recent interim analysis and upsizing of the trial. While the average price target by Wall St. analysts on SNSS is currently around $7.00, an analyst from Leerink raised his price target today to $10.00, and we would expect others to follow suit after tomorrow's meeting

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.92+0.03(+3.36%)Aug 26 3:59 PMEDT